Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy

References

• Arruebo M, Vilaboa N, Sáez-Gutierrez B, Lambea J, Tres A, Valladares M, González-Fernández Á. Assessment of the evolution of cancer treatment therapies. Cancers. 2011;3(3):3279–18. doi:10.3390/cancers3033279.
   PubMedGoogle Scholar
• Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–289. doi:10.3322/caac.21349.
   PubMed Web of Science ®Google Scholar
• Zhang H, Chen J. Current status and future directions of cancer immunotherapy. J Cancer. 2018;9(10):1773. doi:10.7150/jca.24577.
   PubMed Web of Science ®Google Scholar
• Rabinovich GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol. 2007;25:267–296. doi:10.1146/annurev.immunol.25.022106.141609.
   PubMed Web of Science ®Google Scholar
• Palucka K, Banchereau J. Dendritic-cell-based therapeutic cancer vaccines. Immunity. 2013;39(1):38–48. doi:10.1016/j.immuni.2013.07.004.
   PubMed Web of Science ®Google Scholar
• Van Willigen WW, Bloemendal M, Gerritsen WR, Schreibelt G, de Vries IJM, Bol KF. Dendritic cell cancer therapy: vaccinating the right patient at the right time. Front Immunol. 2018 Oct 1;9: 2265.
   Web of Science ®Google Scholar
• Santos PM, Butterfield LH. Dendritic cell–based cancer vaccines. J Immunol. 2018;200(2):443–449. doi:10.4049/jimmunol.1701024.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Bae Y-S. Dendritic cell-based therapeutic cancer vaccines: past, present and future. Clin Exp Vaccine Res. 2014;3(2):113–116. doi:10.7774/cevr.2014.3.2.113.
   PubMedGoogle Scholar
• Mastelic-Gavillet B, Balint K, Boudousquie C, Gannon PO, Kandalaft LE. Personalized dendritic cell vaccines—recent breakthroughs and encouraging clinical results. Front Immunol. 2019;10. doi:10.3389/fimmu.2019.00766.
   Web of Science ®Google Scholar
• Elster JD, Krishnadas DK, Lucas KG. Dendritic cell vaccines: a review of recent developments and their potential pediatric application. Hum Vaccine Immunother. 2016;12(9):2232–2239. doi:10.1080/21645515.2016.1179844.
   PubMed Web of Science ®Google Scholar
• Escola J-M, Kleijmeer MJ, Stoorvogel W, Griffith JM, Yoshie O, Geuze HJ. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem. 1998;273(32):20121–20127. doi:10.1074/jbc.273.32.20121.
   PubMed Web of Science ®Google Scholar
• Morelli AE, Larregina AT, Shufesky WJ, Sullivan MLG, Stolz DB, Papworth GD, Zahorchak AF, Logar AJ, Wang Z, Watkins SC. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood. 2004;104(10):3257–3266. doi:10.1182/blood-2004-03-0824.
   PubMed Web of Science ®Google Scholar
• Hao S, Bai O, Yuan J, Qureshi M, Xiang J. Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes. Cell Mol Immunol. 2006;3:205–211.
   PubMed Web of Science ®Google Scholar
• Gu X, Erb U, Büchler MW, Zöller M. Improved vaccine efficacy of tumor exosome compared to tumor lysate loaded dendritic cells in mice. Int J Cancer. 2015;136(4):E74–E84. doi:10.1002/ijc.29100.
   PubMed Web of Science ®Google Scholar
• Wolfers J, Lozier A, Raposo G, Regnault A, Théry C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med. 2001;7(3):297. doi:10.1038/85438.
   PubMed Web of Science ®Google Scholar
• Andre F, Schartz NEC, Chaput N, Flament C, Raposo G, Amigorena S, Angevin E, Zitvogel L. Tumor-derived exosomes: a new source of tumor rejection antigens. Vaccine. 2002;20:A28–A31. doi:10.1016/S0264-410X(02)00384-5.
   PubMed Web of Science ®Google Scholar
• Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T. Malignant effusions and immunogenic tumour-derived exosomes. Lancet. 2002;360(9329):295–305. doi:10.1016/S0140-6736(02)09552-1.
   PubMed Web of Science ®Google Scholar
• Altieri SL, Khan ANH, Tomasi TB. Exosomes from plasmacytoma cells as a tumor vaccine. J Immunother. 2004;27(4):282–288. doi:10.1097/00002371-200407000-00004.
   PubMed Web of Science ®Google Scholar
• Hong CS, Muller L, Boyiadzis M, Whiteside TL. Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia. PLoS One. 2014;9(8):e103310. doi:10.1371/journal.pone.0103310.
   PubMed Web of Science ®Google Scholar
• Palazzolo G, Albanese NN, DI Cara G, Gygax D, Vittorelli ML, Pucci-Minafra I. Proteomic analysis of exosome-like vesicles derived from breast cancer cells. Anticancer Res. 2012;32:847–860.
   PubMed Web of Science ®Google Scholar
• Xie Y, Zhang H, Li W, Deng Y, Munegowda MA, Chibbar R, Qureshi M, Xiang J. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to Inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity. J Immunol. 2010;185(9):5268–5278. doi:10.4049/jimmunol.1000386.
   PubMed Web of Science ®Google Scholar
• Hwang I, Shen X, Sprent J. Direct stimulation of naive T cells by membrane vesicles from antigen-presenting cells: distinct roles for CD54 and B7 molecules. Proc Natl Acad Sci. 2003;100(11):6670–6675. doi:10.1073/pnas.1131852100.
   PubMed Web of Science ®Google Scholar
• Utsugi-Kobukai S, Fujimaki H, Hotta C, Nakazawa M, Minami M. MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells. Immunol Lett. 2003;89(2–3):125–131. doi:10.1016/S0165-2478(03)00128-7.
   PubMed Web of Science ®Google Scholar
• Hsu D-H, Paz P, Villaflor G, Rivas A, Mehta-Damani A, Angevin E, Zitvogel L, Le Pecq J-B. Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides. J Immunother. 2003;26(5):440–450. doi:10.1097/00002371-200309000-00007.
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G, Amigorena S. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes. Nat Med. 1998;4(5):594. doi:10.1038/nm0598-594.
   PubMed Web of Science ®Google Scholar
• Cho JA, Yeo D-J, Son H-Y, Kim H-W, Jung D-S, Ko J-K, Koh JS, Kim Y-N, Kim C-W. Exosomes: a new delivery system for tumor antigens in cancer immunotherapy. Int J Cancer. 2005;114(4):613–622. doi:10.1002/ijc.20757.
   PubMed Web of Science ®Google Scholar
• Chaput N, Schartz NEC, André F, Taïeb J, Novault S, Bonnaventure P, Aubert N, Bernard J, Lemonnier F, Merad M. Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J Immunol. 2004;172(4):2137–2146. doi:10.4049/jimmunol.172.4.2137.
   PubMed Web of Science ®Google Scholar
• Chiang C, Coukos G, Kandalaft L. Whole tumor antigen vaccines: where are we? Vaccines. 2015;3(2):344–372. doi:10.3390/vaccines3020344.
   PubMed Web of Science ®Google Scholar
• Chaput N, Schartz NEC, Andre F, Zitvogel L. Exosomes for immunotherapy of cancer. In: Handbook of cancer vaccines. Springer; 2004. p. 331–340. Humana Press, Totowa, NJ.
   Google Scholar
• Chen W, Wang J, Shao C, Liu S, Yu Y, Wang Q, Cao X. Efficient induction of antitumor T cell immunity by exosomes derived from heat‐shocked lymphoma cells. Eur J Immunol. 2006;36(6):1598–1607. doi:10.1002/eji.200535501.
   PubMed Web of Science ®Google Scholar
• Lee YS, Kim SH, Cho JA, Kim CW. Introduction of the CIITA gene into tumor cells produces exosomes with enhanced anti-tumor effects. Exp Mol Med. 2011;43(5):281. doi:10.3858/emm.2011.43.5.029.
   PubMed Web of Science ®Google Scholar
• Fan W, Tian X-D, Huang E, Zhang -J-J. Exosomes from CIITA-transfected CT26 cells enhance anti-tumor effects. Asian Pac J Cancer Prev. 2013;14(2):987–991. doi:10.7314/APJCP.2013.14.2.987.
   PubMedGoogle Scholar
• Yao Y, Wang C, Wei W, Shen C, Deng X, Chen L, Ma L, Hao S. Dendritic cells pulsed with leukemia cell-derived exosomes more efficiently induce antileukemic immunities. PLoS One. 2014;9(3):e91463. doi:10.1371/journal.pone.0091463.
   PubMed Web of Science ®Google Scholar
• Keller S, Ridinger J, Rupp A-K, Janssen JW, Altevogt P. Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med. 2011;9(1):86. doi:10.1186/1479-5876-9-86.
   PubMed Web of Science ®Google Scholar
• Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373–383. doi:10.1083/jcb.201211138.
   PubMed Web of Science ®Google Scholar
• Caby M-P, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C. Exosomal-like vesicles are present in human blood plasma. Int Immunol. 2005;17(7):879–887. doi:10.1093/intimm/dxh267.
   PubMed Web of Science ®Google Scholar
• Admyre C, Johansson SM, Qazi KR, Filén -J-J, Lahesmaa R, Norman M, Neve EPA, Scheynius A, Gabrielsson S. Exosomes with immune modulatory features are present in human breast milk. J Immunol. 2007;179(3):1969–1978. doi:10.4049/jimmunol.179.3.1969.
   PubMed Web of Science ®Google Scholar
• Sánchez-Vidaurre S, Eldh M, Larssen P, Daham K, Martinez-Bravo M-J, Dahlén S-E, Dahlén B, van Hage M, Gabrielsson S. RNA-containing exosomes in induced sputum of asthmatic patients. J Allergy Clin Immunol. 2017 e2;140(5):1459–1461. doi:10.1016/j.jaci.2017.05.035.
   PubMed Web of Science ®Google Scholar
• Nilsson J, Skog J, Nordstrand A, Baranov V, Mincheva-Nilsson L, Breakefield XO, Widmark A. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer. 2009;100(10):1603. doi:10.1038/sj.bjc.6605058.
   PubMed Web of Science ®Google Scholar
• Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255–289. doi:10.1146/annurev-cellbio-101512-122326.
   PubMed Web of Science ®Google Scholar
• Keller S, Sanderson MP, Stoeck A, Altevogt P. Exosomes: from biogenesis and secretion to biological function. Immunol Lett. 2006;107(2):102–108. doi:10.1016/j.imlet.2006.09.005.
   PubMed Web of Science ®Google Scholar
• Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262:9412–9420.
   PubMed Web of Science ®Google Scholar
• Harding C, Heuser J, Stahl P. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol. 1983;97(2):329–339. doi:10.1083/jcb.97.2.329.
   PubMed Web of Science ®Google Scholar
• Stoorvogel W, Strous GJ, Geuze HJ, Oorschot V, Schwartzt AL. Late endosomes derive from early endosomes by maturation. Cell. 1991;65(3):417–427. doi:10.1016/0092-8674(91)90459-C.
   PubMed Web of Science ®Google Scholar
• Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569. doi:10.1038/nri855.
   PubMed Web of Science ®Google Scholar
• Raiborg C, Stenmark H. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature. 2009;458(7237):445. doi:10.1038/nature07961.
   PubMed Web of Science ®Google Scholar
• Hurley JH. ESCRT complexes and the biogenesis of multivesicular bodies. Curr Opin Cell Biol. 2008;20(1):4–11. doi:10.1016/j.ceb.2007.12.002.
   PubMed Web of Science ®Google Scholar
• Stuffers S, Sem Wegner C, Stenmark H, Brech A. Multivesicular endosome biogenesis in the absence of ESCRTs. Traffic. 2009;10(7):925–937. doi:10.1111/j.1600-0854.2009.00920.x.
   PubMed Web of Science ®Google Scholar
• Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brugger B, Simons M. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319(5867):1244–1247. doi:10.1126/science.1153124.
   PubMed Web of Science ®Google Scholar
• Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 2010;73(10):1907–1920. doi:10.1016/j.jprot.2010.06.006.
   PubMed Web of Science ®Google Scholar
• Kowal J, Tkach M, Théry C. Biogenesis and secretion of exosomes. Curr Opin Cell Biol. 2014;29:116–125. doi:10.1016/j.ceb.2014.05.004.
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654. doi:10.1038/ncb1596.
   PubMed Web of Science ®Google Scholar
• Willms E, Johansson HJ, Mäger I, Lee Y, Blomberg KEM, Sadik M, Alaarg A, Smith CIE, Lehtiö J, EL Andaloussi S. Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci Rep. 2016;6(1):22519. doi:10.1038/srep22519.
   PubMedGoogle Scholar
• Mathivanan S, Fahner CJ, Reid GE, Simpson RJ. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res. 2011;40(D1):D1241–D1244. doi:10.1093/nar/gkr828.
   PubMed Web of Science ®Google Scholar
• Keerthikumar S, Chisanga D, Ariyaratne D, Al Saffar H, Anand S, Zhao K, Samuel M, Pathan M, Jois M, Chilamkurti N. ExoCarta: a web-based compendium of exosomal cargo. J Mol Biol. 2016;428(4):688–692. doi:10.1016/j.jmb.2015.09.019.
   PubMed Web of Science ®Google Scholar
• Vlassov AV, Magdaleno S, Setterquist R, Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta-Gen Subj. 2012;1820(7):940–948. doi:10.1016/j.bbagen.2012.03.017.
   PubMed Web of Science ®Google Scholar
• Hong C-S, Sharma P, Yerneni SS, Simms P, Jackson EK, Whiteside TL, Boyiadzis M. Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia. Sci Rep. 2017;7(1):14684. doi:10.1038/s41598-017-14661-w.
   PubMed Web of Science ®Google Scholar
• Belting M, Wittrup A. Nanotubes, exosomes, and nucleic acid–binding peptides provide novel mechanisms of intercellular communication in eukaryotic cells: implications in health and disease. J Cell Biol. 2008;183(7):1187–1191. doi:10.1083/jcb.200810038.
   PubMed Web of Science ®Google Scholar
• Kharaziha P, Ceder S, Li Q, Panaretakis T. Tumor cell-derived exosomes: a message in a bottle. Biochim Biophys Acta-Rev Cancer. 2012;1826(1):103–111. doi:10.1016/j.bbcan.2012.03.006.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019;9(1):19. doi:10.1186/s13578-019-0282-2.
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Kang M-H, Jeyaraj M, Qasim M, Kim J-H. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells. 2019;8(4):307. doi:10.3390/cells8040307.
   PubMed Web of Science ®Google Scholar
• Théry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006;30(1):3.22. 1–3.22. 29. doi:10.1002/0471143030.cb0322s30.
   Google Scholar
• Bu H, He D, He X, Wang K. Exosomes: isolation, analysis, and applications in cancer detection and therapy. Chembiochem. 2019;20(4):451–461. doi:10.1002/cbic.201800470.
   PubMed Web of Science ®Google Scholar
• de la Torre Gomez C, Goreham RV, Bech Serra JJ, Nann T, Kussmann M. “Exosomics”—a review of biophysics, biology and biochemistry of exosomes with a focus on human breast milk. Front Genet. 2018;9:92. doi:10.3389/fgene.2018.00092.
   PubMed Web of Science ®Google Scholar
• Carpintero-Fernández P, Fafián-Labora J, O’Loghlen A. Technical advances to study extracellular vesicles. Front Mol Biosci. 2017;4:79. doi:10.3389/fmolb.2017.00079.
   PubMed Web of Science ®Google Scholar
• Tickner JA, Urquhart AJ, Stephenson S-A, Richard DJ, O’Byrne KJ. Functions and therapeutic roles of exosomes in cancer. Front Oncol. 2014;4:127. doi:10.3389/fonc.2014.00127.
   PubMedGoogle Scholar
• Melo SA, Sugimoto H, O’Connell JT, Kato N, Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, et al. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell. 2014;26(5):707–721. doi:10.1016/j.ccell.2014.09.005.
   PubMed Web of Science ®Google Scholar
• Ciardiello C, Leone A, Budillon A. The crosstalk between cancer stem cells and microenvironment is critical for solid tumor progression: the significant contribution of extracellular vesicles. Stem Cells Int. 2018;2018:1–11. doi:10.1155/2018/6392198.
   Web of Science ®Google Scholar
• Carnero A, Garcia-Mayea Y, Mir C, Lorente J, Rubio IT, LLeonart ME. The cancer stem-cell signaling network and resistance to therapy. Cancer Treat Rev. 2016;49:25–36. doi:10.1016/j.ctrv.2016.07.001.
   PubMed Web of Science ®Google Scholar
• Pan Q, Li Q, Liu S, Ning N, Zhang X, Xu Y, Chang AE, Wicha MS. Concise review: targeting cancer stem cells using immunologic approaches. Stem Cells. 2015;33(7):2085–2092. doi:10.1002/stem.2039.
   PubMed Web of Science ®Google Scholar
• Madjd Z, Gheytanchi E, Erfani E, Asadi-Lari M. Application of stem cells in targeted therapy of breast cancer: a systematic review. Asian Pac J Cancer Prev. 2013;14(5):2789–2800. doi:10.7314/APJCP.2013.14.5.2789.
   PubMedGoogle Scholar
• Sun Z, Wang L, Dong L, Wang X. Emerging role of exosome signalling in maintaining cancer stem cell dynamic equilibrium. J Cell Mol Med. 2018;22(8):3719–3728. doi:10.1111/jcmm.13676.
   PubMed Web of Science ®Google Scholar
• Valcz G, Buzás EI, Szállási Z, Kalmár A, Krenács T, Tulassay Z, Igaz P, Molnár B. Perspective: bidirectional exosomal transport between cancer stem cells and their fibroblast-rich microenvironment during metastasis formation. NPJ Breast Cancer. 2018;4(1):18. doi:10.1038/s41523-018-0071-9.
   PubMedGoogle Scholar
• Xu J, Liao K, Zhou W. Exosomes regulate the transformation of cancer cells in cancer stem cell homeostasis. Stem Cells Int. 2018;2018.
   Web of Science ®Google Scholar
• Sánchez CA, Andahur EI, Valenzuela R, Castellón EA, Fullá JA, Ramos CG, Triviño JC. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche. Oncotarget. 2016;7(4):3993. doi:10.18632/oncotarget.6540.
   PubMedGoogle Scholar
• Grange C, Tapparo M, Collino F, Vitillo L, Damasco C, Deregibus MC, Tetta C, Bussolati B, Camussi G. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res. 2011;71(15):5346–5356. doi:10.1158/0008-5472.CAN-11-0241.
   PubMed Web of Science ®Google Scholar
• Conigliaro A, Costa V, Lo Dico A, Saieva L, Buccheri S, Dieli F, Manno M, Raccosta S, Mancone C, Tripodi M. CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. Mol Cancer. 2015;14(1):155. doi:10.1186/s12943-015-0426-x.
   PubMedGoogle Scholar
• Wan Z, Gao X, Dong Y, Zhao Y, Chen X, Yang G, Liu L. Exosome-mediated cell-cell communication in tumor progression. Am J Cancer Res. 2018;8:1661.
   PubMed Web of Science ®Google Scholar
• Chairoungdua A, Smith DL, Pochard P, Hull M, Caplan MJ. Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol. 2010;190(6):1079–1091. doi:10.1083/jcb.201002049.
   PubMed Web of Science ®Google Scholar
• Hong BS, Cho J-H, Kim H, Choi E-J, Rho S, Kim J, Kim J, Choi D-S, Kim Y-K, Hwang D, et al. Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics. 2009;10(1):556. doi:10.1186/1471-2164-10-556.
   PubMedGoogle Scholar
• Qu J-L, Qu X-J, Zhao M-F, Teng Y-E, Zhang Y, Hou K-Z, Jiang Y-H, Yang X-H, Liu Y-P. Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation. Digest Liver Dis. 2009;41(12):875–880. doi:10.1016/j.dld.2009.04.006.
   Web of Science ®Google Scholar
• Yu S, Liu C, Su K, Wang J, Liu Y, Zhang L, Li C, Cong Y, Kimberly R, Grizzle WE, et al. Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J Immunol. 2007;178(11):6867–6875. doi:10.4049/jimmunol.178.11.6867.
   PubMed Web of Science ®Google Scholar
• Chow A, Zhou W, Liu L, Fong MY, Champer J, Van Haute D, Chin AR, Ren X, Gugiu BG, Meng Z, et al. Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κB. Sci Rep. 2014;4:5750. doi:10.1038/srep05750.
   PubMed Web of Science ®Google Scholar
• Menck K, Klemm F, Gross JC, Pukrop T, Wenzel D, Binder C. Induction and transport of Wnt 5a during macrophage-induced malignant invasion is mediated by two types of extracellular vesicles. Oncotarget. 2013;4(11):2057. doi:10.18632/oncotarget.1336.
   PubMedGoogle Scholar
• Marton A, Vizler C, Kusz E, Temesfoi V, Szathmary Z, Nagy K, Szegletes Z, Varo G, Siklos L, Katona RL. Melanoma cell-derived exosomes alter macrophage and dendritic cell functions in vitro. Immunol Lett. 2012;148(1):34–38. doi:10.1016/j.imlet.2012.07.006.
   PubMed Web of Science ®Google Scholar
• Kogure T, Lin W-L, Yan IK, Braconi C, Patel T. Intercellular nanovesicle‐mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology. 2011;54(4):1237–1248. doi:10.1002/hep.24504.
   PubMed Web of Science ®Google Scholar
• Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, García-Santos G, Ghajar CM, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012;18(6):883.
   PubMed Web of Science ®Google Scholar
• Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009;9(8):581. doi:10.1038/nri2567.
   PubMed Web of Science ®Google Scholar
• Le MT, Hamar P, Guo C, Basar E, Perdigão-Henriques R, Balaj L, Lieberman J. miR-200–containing extracellular vesicles promote breast cancer cell metastasis. J Clin Invest. 2014;124(12):5109–5128. doi:10.1172/JCI75695.
   PubMed Web of Science ®Google Scholar
• Zomer A, Maynard C, Verweij F, Kamermans A, Schäfer R, Beerling E, Schiffelers R, de Wit E, Berenguer J, Ellenbroek S. In vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior. Cell. 2015;161(5):1046–1057. doi:10.1016/j.cell.2015.04.042.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Sawada K, Kinose Y, Yoshimura A, Toda A, Nakatsuka E, Hashimoto K, Mabuchi S, Morishige KI, Kurachi H, et al. Exosomes promote ovarian cancer cell invasion through transfer of CD44 to peritoneal mesothelial cells. Mol Cancer Res. 2017 Jan 1;15(1):78-92.
   Web of Science ®Google Scholar
• Hoshino D, Kirkbride K, Costello K, Clark E, Sinha S, Grega-Larson N, Tyska M, Weaver A. Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Rep. 2013;5(5):1159–1168. doi:10.1016/j.celrep.2013.10.050.
   PubMed Web of Science ®Google Scholar
• Muralidharan-Chari V, Clancy J, Plou C, Romao M, Chavrier P, Raposo G, D’Souza-Schorey C. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol. 2009;19(22):1875–1885. doi:10.1016/j.cub.2009.09.059.
   PubMed Web of Science ®Google Scholar
• Lazar I, Clement E, Dauvillier S, Milhas D, Ducoux-Petit M, LeGonidec S, Moro C, Soldan V, Dalle S, Balor S. Adipocyte exosomes promote melanoma aggressiveness through fatty acid oxidation: a novel mechanism linking obesity and cancer. Cancer Res. 2016;76(14):4051–4057. canres. 0651.2016. doi:10.1158/0008-5472.CAN-16-0651.
   PubMed Web of Science ®Google Scholar
• Millimaggi D, Mari M, D’Ascenzo S, Carosa E, Jannini EA, Zucker S, Carta G, Pavan A, Dolo V. Tumor vesicle—associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia. 2007;9(4):349–357. doi:10.1593/neo.07133.
   PubMed Web of Science ®Google Scholar
• Guo Y, Ji X, Liu J, Fan D, Zhou Q, Chen C, Wang W, Wang G, Wang H, Yuan W. Effects of exosomes on pre-metastatic niche formation in tumors. Mol Cancer. 2019;18(1):39. doi:10.1186/s12943-019-0995-1.
   PubMed Web of Science ®Google Scholar
• Rana S, Malinowska K, Zöller M. Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia. 2013;15(3):IN14–IN31. doi:10.1593/neo.122010.
   Web of Science ®Google Scholar
• Hoshino A, Costa-Silva B, Shen T-L, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527(7578):329. doi:10.1038/nature15756.
   PubMed Web of Science ®Google Scholar
• Greening DW, Gopal SK, Mathias RA, Liu L, Sheng J, Zhu H-J, Simpson RJ. Emerging roles of exosomes during epithelial–mesenchymal transition and cancer progression. Semin Cell Dev Biol. 2015;40:60–71. Elsevier. doi:10.1016/j.semcdb.2015.02.008.
   PubMed Web of Science ®Google Scholar
• Vella LJ. The emerging role of exosomes in epithelial–mesenchymal-transition in cancer. Front Oncol. 2014;4:361. doi:10.3389/fonc.2014.00361.
   PubMedGoogle Scholar
• Valenzuela MMA, Ferguson Bennit HR, Gonda A, Diaz Osterman CJ, Hibma A, Khan S, Wall NR. Exosomes secreted from human cancer cell lines contain inhibitors of apoptosis (IAP). Cancer Microenviron. 2015;8(2):65–73. doi:10.1007/s12307-015-0167-9.
   PubMed Web of Science ®Google Scholar
• Yang L, Wu X-H, Wang D, Luo C-L, Chen L-X. Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro. Mol Med Rep. 2013;8(4):1272–1278. doi:10.3892/mmr.2013.1634.
   PubMed Web of Science ®Google Scholar
• Khan S, Jutzy JMS, Aspe JR, McGregor DW, Neidigh JW, Wall NR. Survivin is released from cancer cells via exosomes. Apoptosis. 2011;16(1):1–12. doi:10.1007/s10495-010-0534-4.
   PubMed Web of Science ®Google Scholar
• Taverna S, Flugy A, Saieva L, Kohn EC, Santoro A, Meraviglia S, De Leo G, Alessandro R. Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis. Int J Cancer. 2012;130(9):2033–2043. doi:10.1002/ijc.26217.
   PubMed Web of Science ®Google Scholar
• Wang J, De Veirman K, Faict S, Frassanito MA, Ribatti D, Vacca A, Menu E. Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression. J Pathol. 2016;239(2):162–173. doi:10.1002/path.4712.
   PubMed Web of Science ®Google Scholar
• Hood JL, Pan H, Lanza GM, Wickline SA. Paracrine induction of endothelium by tumor exosomes. Lab Invest. 2009;89(11):1317. doi:10.1038/labinvest.2009.94.
   PubMed Web of Science ®Google Scholar
• Gopal SK, Greening DW, Hanssen EG, Zhu H-J, Simpson RJ, Mathias RA. Oncogenic epithelial cell-derived exosomes containing Rac1 and PAK2 induce angiogenesis in recipient endothelial cells. Oncotarget. 2016;7(15):19709. doi:10.18632/oncotarget.7573.
   PubMedGoogle Scholar
• Aslan C, Maralbashi S, Salari F, Kahroba H, Sigaroodi F, Kazemi T, Kharaziha P. Tumor‐derived exosomes: implication in angiogenesis and antiangiogenesis cancer therapy. J Cell Physiol. 2019;234(10):16885–16903. doi:10.1002/jcp.28374.
   PubMed Web of Science ®Google Scholar
• Ludwig N, Whiteside TL. Potential roles of tumor-derived exosomes in angiogenesis. Expert Opin Ther Targets. 2018;22(5):409–417. doi:10.1080/14728222.2018.1464141.
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Hagiwara K, Yoshioka Y, Takeshita F, Ochiya T. Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J Biol Chem. 2013 Apr 12;288(15):10849–10859.
   Web of Science ®Google Scholar
• Fan G-C. Hypoxic exosomes promote angiogenesis. Blood. 2014;124(25):3669–3670. doi:10.1182/blood-2014-10-607846.
   PubMed Web of Science ®Google Scholar
• Tadokoro H, Umezu T, Ohyashiki K, Hirano T, Ohyashiki JH. Exosomes derived from hypoxic leukemia cells enhance tube formation in endothelial cells. J Biol Chem. 2013 Nov 29;288(48):34343–34351.
   Web of Science ®Google Scholar
• Yang H, Zhang H, Ge S, Ning T, Bai M, Li J, Li S, Sun W, Deng T, Zhang L. Exosome-derived miR-130a activates angiogenesis in gastric Cancer by targeting C-MYB in vascular endothelial cells. Mol Ther. 2018;26(10):2466–2475. doi:10.1016/j.ymthe.2018.07.023.
   PubMed Web of Science ®Google Scholar
• Chen W-X, Liu X-M, Lv -M-M, Chen L, Zhao J-H, Zhong S-L, Ji M-H, Hu Q, Luo Z, Wu J-Z, et al. Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLoS One. 2014;9(4):e95240. doi:10.1371/journal.pone.0095240.
   PubMed Web of Science ®Google Scholar
• Zhao L, Liu W, Xiao J, Cao B. The role of exosomes and “exosomal shuttle microRNA” in tumorigenesis and drug resistance. Cancer Lett. 2015;356(2):339–346. doi:10.1016/j.canlet.2014.10.027.
   PubMed Web of Science ®Google Scholar
• Xu C, Yang M-F, Ren Y-Q, Wu C-H, Wang L-Q. Exosomes mediated transfer of lncRNA UCA1 results in increased tamoxifen resistance in breast cancer cells. Eur Rev Med Pharmacol Sci. 2016;20:4362–4368.
   PubMed Web of Science ®Google Scholar
• Khan S, Aspe JR, Asumen MG, Almaguel F, Odumosu O, Acevedo-Martinez S, De Leon M, Langridge WHR, Wall NR. Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. Br J Cancer. 2009;100(7):1073. doi:10.1038/sj.bjc.6604978.
   PubMed Web of Science ®Google Scholar
• Fu X, Liu M, Qu S, Ma J, Zhang Y, Shi T, Wen H, Yang Y, Wang S, Wang J. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway. J Exp Clin Cancer Res. 2018;37(1):52. doi:10.1186/s13046-018-0677-7.
   PubMed Web of Science ®Google Scholar
• Mashouri L, Yousefi H, Aref AR, Ahadi AM, Molaei F, Alahari SK. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer. 2019;18(1):75. doi:10.1186/s12943-019-0991-5.
   PubMed Web of Science ®Google Scholar
• Whiteside TL, Mandapathil M, Szczepanski M, Szajnik M. Mechanisms of tumor escape from the immune system: adenosine-producing Treg, exosomes and tumor-associated TLRs. Bull Cancer. 2011;98(2):E25–E31. doi:10.1684/bdc.2010.1294.
   PubMed Web of Science ®Google Scholar
• Liu C, Yu S, Zinn K, Wang J, Zhang L, Jia Y, Kappes JC, Barnes S, Kimberly RP, Grizzle WE. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol. 2006;176(3):1375–1385. doi:10.4049/jimmunol.176.3.1375.
   PubMed Web of Science ®Google Scholar
• Ashiru O, Boutet P, Fernandez-Messina L, Aguera-Gonzalez S, Skepper JN, Vales-Gomez M, Reyburn HT. Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA* 008 that is shed by tumor cells in exosomes. Cancer Res. 2010;70(2):481–489. doi:10.1158/0008-5472.CAN-09-1688.
   PubMed Web of Science ®Google Scholar
• Liu C, Yu S, Kappes J, Wang J, Grizzle WE, Zinn KR, Zhang H-G. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood. 2007;109(10):4336–4342. doi:10.1182/blood-2006-09-046201.
   PubMed Web of Science ®Google Scholar
• Katsiougiannis S, Chia D, Kim Y, Singh RP, Wong DTW. Saliva exosomes from pancreatic tumor–bearing mice modulate NK cell phenotype and antitumor cytotoxicity. Faseb J. 2016;31(3):998–1010. doi:10.1096/fj.201600984R.
   PubMed Web of Science ®Google Scholar
• Szczepanski MJ, Szajnik M, Welsh A, Whiteside TL, Boyiadzis M. Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-β1. Haematologica. 2011;96(9):1302–1309. doi:10.3324/haematol.2010.039743.
   PubMed Web of Science ®Google Scholar
• Xia Y, Zhang Q, Zhen Q, Zhao Y, Liu N, Li T, Hao Y, Zhang Y, Luo C, Wu X. Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway. Oncotarget. 2017;8(23):37783. doi:10.18632/oncotarget.16354.
   PubMedGoogle Scholar
• Zhang H-G, Kim H, Liu C, Yu S, Wang J, Grizzle WE, Kimberly RP, Barnes S. Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity. Biochim Biophys Acta Mol Cell Res. 2007;1773(7):1116–1123. doi:10.1016/j.bbamcr.2007.04.015.
   PubMed Web of Science ®Google Scholar
• Gastpar R, Gehrmann M, Bausero MA, Asea A, Gross C, Schroeder JA, Multhoff G. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res. 2005;65(12):5238–5247. doi:10.1158/0008-5472.CAN-04-3804.
   PubMed Web of Science ®Google Scholar
• Lv L-H, Wan Y-L, Lin Y, Zhang W, Yang M, Li G-L, Lin H-M, Shang C-Z, Chen Y-J, Min J. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro. J Biol Chem. 2012;287(19):15874–15885. doi:10.1074/jbc.M112.340588.
   PubMed Web of Science ®Google Scholar
• Czernek L, Düchler M. Functions of cancer-derived extracellular vesicles in immunosuppression. Arch Immunol Ther Exp (Warsz). 2017;65(4):311–323. doi:10.1007/s00005-016-0453-3.
   PubMed Web of Science ®Google Scholar
• Song X, Ding Y, Liu G, Yang X, Zhao R, Zhang Y, Zhao X, Anderson GJ, Nie G. Cancer cell-derived exosomes induce mitogen-activated protein kinase-dependent monocyte survival by transport of functional receptor tyrosine kinases. J Biol Chem. 2016;291(16):8453–8464. doi:10.1074/jbc.M116.716316.
   PubMed Web of Science ®Google Scholar
• Maia J, Caja S, Strano Moraes MC, Couto N, Costa-Silva B. Exosome-based cell-cell communication in the tumor microenvironment. Front Cell Dev Biol. 2018;6:18. doi:10.3389/fcell.2018.00018.
   PubMed Web of Science ®Google Scholar
• Liu Y, Gu Y, Cao X. The exosomes in tumor immunity. Oncoimmunology. 2015;4(9):e1027472. doi:10.1080/2162402X.2015.1027472.
   PubMed Web of Science ®Google Scholar
• Yang C, Kim S-H, Bianco NR, Robbins PD. Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model. PLoS One. 2011;6(8):e22517. doi:10.1371/journal.pone.0022517.
   PubMed Web of Science ®Google Scholar
• Xiang X, Poliakov A, Liu C, Liu Y, Deng Z-B, Wang J, Cheng Z, Shah SV, Wang G-J, Zhang L. Induction of myeloid‐derived suppressor cells by tumor exosomes. Int J Cancer. 2009;124(11):2621–2633. doi:10.1002/ijc.24249.
   PubMed Web of Science ®Google Scholar
• Liu H, Chen L, Peng Y, Yu S, Liu J, Wu L, Zhang L, Wu Q, Chang X, Yu X, et al. Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy. Oncotarget. 2018;9(2):2887. doi:10.18632/oncotarget.20812.
   PubMedGoogle Scholar
• Ren G, Wang Y, Yuan S, Wang B. Dendritic cells loaded with HeLa-derived exosomes simulate an antitumor immune response. Oncol Lett. 2018;15(5):6636–6640. doi:10.3892/ol.2018.8126.
   PubMed Web of Science ®Google Scholar
• Taylor DD, Gerçel-Taylor C, Lyons KS, Stanson J, Whiteside TL. T-cell apoptosis and suppression of T-cell receptor/CD3-ζ by Fas ligand-containing membrane vesicles shed from ovarian tumors. Clin Cancer Res. 2003;9:5113–5119.
   PubMed Web of Science ®Google Scholar
• Kunigelis K, Graner M. The dichotomy of tumor exosomes (TEX) in cancer immunity: is it all in the ConTEXt? Vaccines. 2015;3(4):1019–1051. doi:10.3390/vaccines3041019.
   PubMed Web of Science ®Google Scholar
• Andreola G, Rivoltini L, Castelli C, Huber V, Perego P, Deho P, Squarcina P, Accornero P, Lozupone F, Lugini L. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med. 2002;195(10):1303–1316. doi:10.1084/jem.20011624.
   PubMed Web of Science ®Google Scholar
• Maybruck BT, Pfannenstiel LW, Diaz-Montero M, Gastman BR. Tumor-derived exosomes induce CD8+ T cell suppressors. J Immunother Cancer. 2017;5(1):65. doi:10.1186/s40425-017-0269-7.
   PubMedGoogle Scholar
• Clayton A, Al-Taei S, Webber J, Mason MD, Tabi Z. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J Immunol. 2011;187(2):676–683. doi:10.4049/jimmunol.1003884.
   PubMed Web of Science ®Google Scholar
• Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res. 2007;67(15):7458–7466. doi:10.1158/0008-5472.CAN-06-3456.
   PubMed Web of Science ®Google Scholar
• Qazi KR, Torregrosa Paredes P, Dahlberg B, Grunewald J, Eklund A, Gabrielsson S. Proinflammatory exosomes in bronchoalveolar lavage fluid of patients with sarcoidosis. Thorax. 2010;65(11):1016–1024. doi:10.1136/thx.2009.132027.
   PubMed Web of Science ®Google Scholar
• Wieckowski EU, Visus C, Szajnik M, Szczepanski MJ, Storkus WJ, Whiteside TL. Tumor-derived microvesicles promote regulatory t cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J Immunol. 2009;183(6):3720–3730. doi:10.4049/jimmunol.0900970.
   PubMed Web of Science ®Google Scholar
• Hao S, Bai O, Li F, Yuan J, Laferte S, Xiang J. Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T‐lymphocyte responses and antitumour immunity. Immunology. 2007;120(1):90–102. doi:10.1111/j.1365-2567.2006.02483.x.
   PubMed Web of Science ®Google Scholar
• Ye L, Zhang Q, Cheng Y, Chen X, Wang G, Shi M, Zhang T, Cao Y, Pan H, Zhang L. Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1+ regulatory B cell expansion. J Immunother Cancer. 2018;6(1):145. doi:10.1186/s40425-018-0451-6.
   PubMed Web of Science ®Google Scholar
• Yang C, Chalasani G, Ng Y-H, Robbins PD. Exosomes released from mycoplasma infected tumor cells activate inhibitory B cells. PLoS One. 2012;7(4):e36138. doi:10.1371/journal.pone.0036138.
   PubMed Web of Science ®Google Scholar
• Battke C, Ruiss R, Welsch U, Wimberger P, Lang S, Jochum S, Zeidler R. Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC. Cancer Immunol Immunother. 2011;60(5):639–648. doi:10.1007/s00262-011-0979-5.
   PubMed Web of Science ®Google Scholar
• Bu N, Li Q-L, Feng Q, Sun B-Z. Immune protection effect of exosomes against attack of L1210 tumor cells. Leuk Lymphoma. 2006;47(5):913–918. doi:10.1080/10428190500376191.
   PubMed Web of Science ®Google Scholar
• Lee E-Y, Park K-S, Yoon YJ, Lee J, Moon H-G, Jang SC, Choi K-H, Kim Y-K, Gho YS. Therapeutic effects of autologous tumor-derived nanovesicles on melanoma growth and metastasis. PLoS One. 2012;7(3):e33330. doi:10.1371/journal.pone.0033330.
   PubMed Web of Science ®Google Scholar
• Mahaweni NM, Kaijen-Lambers MEH, Dekkers J, Aerts JGJV, Hegmans JPJJ. Tumour-derived exosomes as antigen delivery carriers in dendritic cell-based immunotherapy for malignant mesothelioma. J Extracell Vesicles. 2013;2(1):22492. doi:10.3402/jev.v2i0.22492.
   PubMedGoogle Scholar
• Yang Y, Xiu F, Cai Z, Wang J, Wang Q, Fu Y, Cao X. Increased induction of antitumor response by exosomes derived from interleukin-2 gene-modified tumor cells. J Cancer Res Clin Oncol. 2007;133(6):389–399. doi:10.1007/s00432-006-0184-7.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Luo C-L, He B-C, Zhang J-M, Cheng G, Wu X-H. Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma. Int J Oncol. 2010;36:133–140.
   PubMed Web of Science ®Google Scholar
• Meazza R, Comes A, Orengo A, Ferrini S, Accolla R. Tumor rejection by gene transfer of the MHC class II transactivator in murine mammary adenocarcinoma cells. Eur J Immunol. 2003;33(5):1183–1192. doi:10.1002/eji.200323712.
   PubMed Web of Science ®Google Scholar
• Rao Q, Zuo B, Lu Z, Gao X, You A, Wu C, Du Z, Yin H. Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro. Hepatology. 2016;64(2):456–472. doi:10.1002/hep.28549.
   PubMed Web of Science ®Google Scholar
• Klimp A, de Vries EGE, Scherphof GL, Daemen T. A potential role of macrophage activation in the treatment of cancer. Crit Rev Oncol Hematol. 2002;44(2):143–161. doi:10.1016/S1040-8428(01)00203-7.
   PubMed Web of Science ®Google Scholar
• Zeng Y, Feng H, Graner MW, Katsanis E. Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity. Blood. 2003;101(11):4485–4491. doi:10.1182/blood-2002-10-3108.
   PubMed Web of Science ®Google Scholar
• Feng H, Zeng Y, Whitesell L, Katsanis E. Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity. Blood. 2001;97(11):3505–3512. doi:10.1182/blood.V97.11.3505.
   PubMed Web of Science ®Google Scholar
• Xie Y, Bai O, Zhang H, Yuan J, Zong S, Chibbar R, Slattery K, Qureshi M, Wei Y, Deng Y. Membrane‐bound HSP70‐engineered myeloma cell‐derived exosomes stimulate more efficient CD8+ CTL‐and NK‐mediated antitumour immunity than exosomes released from heat‐shocked tumour cells expressing cytoplasmic HSP70. J Cell Mol Med. 2010;14(11):2655–2666. doi:10.1111/j.1582-4934.2009.00851.x.
   PubMed Web of Science ®Google Scholar
• Xiao L, Erb U, Zhao K, Hackert T, Zöller M. Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer. Oncoimmunology. 2017;6(6):e1319044. doi:10.1080/2162402X.2017.1319044.
   PubMed Web of Science ®Google Scholar
• Xiu F, Cai Z, Yang Y, Wang X, Wang J, Cao X. Surface anchorage of superantigen SEA promotes induction of specific antitumor immune response by tumor-derived exosomes. J Mol Med. 2007;85(5):511–521. doi:10.1007/s00109-006-0154-1.
   PubMed Web of Science ®Google Scholar
• Temchura VV, Tenbusch M, Nchinda G, Nabi G, Tippler B, Zelenyuk M, Wildner O, Überla K, Kuate S. Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus. Vaccine. 2008;26(29–30):3662–3672. doi:10.1016/j.vaccine.2008.04.069.
   PubMed Web of Science ®Google Scholar
• Ohno S-I, Takanashi M, Sudo K, Ueda S, Ishikawa A, Matsuyama N, Fujita K, Mizutani T, Ohgi T, Ochiya T. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther. 2013;21(1):185–191. doi:10.1038/mt.2012.180.
   PubMed Web of Science ®Google Scholar
• Morishita M, Takahashi Y, Matsumoto A, Nishikawa M, Takakura Y. Exosome-based tumor antigens–adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA. Biomaterials. 2016;111:55–65. doi:10.1016/j.biomaterials.2016.09.031.
   PubMed Web of Science ®Google Scholar
• Palmer DH, Midgley RS, Mirza N, Torr EE, Ahmed F, Steele JC, Steven NM, Kerr DJ, Young LS, Adams DH. A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma. Hepatology. 2009;49(1):124–132. doi:10.1002/hep.22626.
   PubMed Web of Science ®Google Scholar
• Cho J-A, Lee Y-S, Kim S-H, Ko J-K, Kim C-W. MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models. Cancer Lett. 2009;275(2):256–265. doi:10.1016/j.canlet.2008.10.021.
   PubMed Web of Science ®Google Scholar
• Nath S, Mukherjee P. MUC1: a multifaceted oncoprotein with a key role in cancer progression. Trends Mol Med. 2014;20(6):332–342. doi:10.1016/j.molmed.2014.02.007.
   PubMed Web of Science ®Google Scholar
• Taghikhani A, Hassan ZM, Ebrahimi M, Moazzeni S-M. microRNA modified tumor‐derived exosomes as novel tools for maturation of dendritic cells. J Cell Physiol. 2019;234(6):9417–9427. doi:10.1002/jcp.27626.
   PubMed Web of Science ®Google Scholar
• Bu N, Wu H, Sun B, Zhang G, Zhan S, Zhang R, Zhou L. Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma. J Neurooncol. 2011;104(3):659–667. doi:10.1007/s11060-011-0537-1.
   PubMed Web of Science ®Google Scholar
• Shi S, Rao Q, Zhang C, Zhang X, Qin Y, Niu Z. Dendritic cells pulsed with exosomes in combination with PD-1 antibody increase the efficacy of sorafenib in hepatocellular carcinoma model. Transl Oncol. 2018;11(2):250–258. doi:10.1016/j.tranon.2018.01.001.
   PubMed Web of Science ®Google Scholar